Contents

Current Neuropharmacology, Volume 13 - Number 5

Meet Our Editorial Board Member:

, 13(5): 555

Michel Baudry


DOI: 10.2174/1570159X1305151013194644




Editorial

Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders)

, 13(5): 556 - 557

Andre F. Carvalho and Roger S. McIntyre


DOI: 10.2174/1570159X1305151013195022




The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments

, 13(5): 558 - 576

Beatrice Bortolato, Andre F. Carvalho, Joanna K. Soczynska, Giulia I. Perini and Roger S. McIntyre


DOI: 10.2174/1570159X13666150630171433





Treatment-resistant Late-life Depression: Challenges and Perspectives

, 13(5): 577 - 591

Christian Knochel, Gilberto Alves, Benedikt Friedrichs, Barbara Schneider, Anna Schmidt-Rechau, Sofia Wenzler, Angelina Schneider, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel


DOI: 10.2174/1570159X1305151013200032





Pharmacological Approaches for Treatment-resistant Bipolar Disorder

, 13(5): 592 - 604

Shi Hui Poon, Kang Sim and Ross J. Baldessarini


DOI: 10.2174/1570159X13666150630171954





From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings

, 13(5): 605 - 615

Konstantinos N. Fountoulakis, Roger S. McIntyre and Andre F. Carvalho


DOI: 10.2174/1570159X13666150630174343





Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics

, 13(5): 616 - 635

Rafael T. de Sousa, Marcus V. Zanetti, Andre R. Brunoni and Rodrigo Machado-Vieira


DOI: 10.2174/1570159X13666150630173522





Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

, 13(5): 636 - 655

Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho


DOI: 10.2174/1570159X13666150630175044





Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

, 13(5): 656 - 662

Seetal Dodd, Brisa S. Fernandes and Olivia M. Dean


DOI: 10.2174/1570159X13666150630175841





Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

, 13(5): 663 - 680

Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel


DOI: 10.2174/1570159X13666150630173047





The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis

, 13(5): 681 - 691

Jennifer E. Thomas, Joshua Caballero and Catherine A. Harrington


DOI: 10.2174/1570159X13666150115220221





The Management and Outcomes of Pharmacological Treatments for Tinnitus

, 13(5): 692 - 700

Devon Beebe Palumbo, Kathleen Joos, Dirk De Ridder and Sven Vanneste


DOI: 10.2174/1570159X13666150415002743




Myalgic Encephalomyelitis: Symptoms and Biomarkers

, 13(5): 701 - 734

Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn


DOI: 10.2174/1570159X13666150928105725





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science